Nuzenio

Amgen Weight Loss

Amgen Weight Loss news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 00:23:49 GMTAmgen Reports Strong Q2 Drug Sales, Raises Guidance, and Will End Early-Stage Weight-Loss Drug Development - Bitget
Tue, 04 Aug 2026 20:23:55 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce Biotech
Tue, 04 Aug 2026 20:07:57 GMTAmgen Raises 2026 Sales Forecast After Strong Q2 Beat - Briefs Finance
Mon, 03 Aug 2026 13:16:14 GMTAmgen Weight Loss Drug: MariTide Review – Is Monthly Dosing the Edge Over Weekly Options? *XTayL406T* - Diario AS
Wed, 29 Jul 2026 07:00:00 GMTWatch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients - Yahoo Finance
Wed, 29 Jul 2026 07:00:00 GMTAmgen's MariTide Aims to Disrupt Obesity Drug Market - Intellectia AI

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Amgen Weight Loss.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.